Combating the emergence and spread of antimicrobial resistant infectious dieseases in Vietnam - V-RESIST

What we aim to achieve:  

Preservation of the effectiveness of life-saving antibiotics, particularly for respiratory diseases such as tuberculosis.

How we will achieve it:   

Through a program of research to understand and target the drivers of drug resistance, and by developing and assessing the effectiveness of a package of interventions to guide the Vietnamese government.

Partners:

  • University of New South Wales
  • Burnet Institute
  • University of Melbourne
  • Australian National University
  • Hanoi Medical University, Vietnam
  • Vietnam Ministry of Health
  • National Lung Hospital, Vietnam
  • National Institute of Hygiene and Epidemiology, Vietnam
  • Pasteur Institute, Vietnam
  • Health Strategy and Policy Institute, Vietnam
  • Oxford University Clinical Research Unit, Vietnam
  • Medicine and Pharmacy University, Vietnam
  • Karolinska Institutet, Sweden
  • Woolcock Institute of Medical Research Limited

Where:

Vietnam

Drug resistant infections are on the rise across the Indo-Pacific region, leading to poor treatment outcomes. Drug resistant tuberculosis and respiratory pathogens are increasingly common and pose a major threat to health in Vietnam and the region. Antimicrobial-resistant infectious diseases are also a top priority for Vietnam, topping its list of priorities in the 2015 Vietnam Global Health Security Roadmap. The project will be done in 36 Districts in population of over five million people. 

    Funding: $2,480,000

    Program Manager:

    Associate Professor Gregory Fox

    University of Sydney Press Release